former was characterized by diffuse collagen deposition and interstitial fibrosis, while the latter showed organized concentric collagen IV deposition within obliterated vessel lumen, suggestive of waves of endothelial cell apoptosis, leaving behind layers of basement membrane deposits as a stress response. Conclusions: Based on these observations, we hypothesize that, apart from their well-known cardiac and vasodilatory effects, β-antagonists could induce endothelial cell apoptosis in IH leading to endovascular occlusion and we present supporting evidence to explain why this response might be specific to hypoxic tissue.
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Background
Infantile capillary hemangioma (IH) is the most common benign tumor of childhood, affecting approximately 4-5% of infants, and up to a third of premature infants [1] . IHs are characterized by an initial proliferative phase Keywords Infantile capillary hemangioma · Topical β-blocker · Topical timolol maleate 0.5% Abstract Background: Infantile capillary hemangiomas (IHs) affect approximately 4-5% of infants. The systemic nonselective β-adrenergic antagonist, propranolol, has become the standard first-line treatment for severe IHs. The topical β-antagonist, timolol maleate, has also demonstrated efficacy and safety in treating superficial and some deep capillary hemangiomas. Despite their therapeutic success and prevalent use, the mechanism of action of β-adrenergic antagonists in the treatment of IHs is not well understood. Methods: Histopathological and electron microscopic evaluation of two periocular IHs excised at 1 week and 24 months following topical timolol treatment was performed. Results: Distinct morphological differences were observed between spontaneously regressed and β-antagonist-treated IHs. The (from birth up to the age of 1 year) followed by slow spontaneous involution lasting up to 10 years. While benign, IH may cause disfigurement and other serious complications. Periocular IH may lead to rapid onset of vision loss from amblyopia due to secondary astigmatism, anisometropia, and strabismus and, therefore, may require immediate intervention to prevent permanent sight loss.
Since the serendipitous observation of efficacy of the nonselective β 1 /β 2 -adrenergic antagonist propranolol in treating IH, significant advances have been made [2] . The clinical use of β-antagonists either orally or topically has been shown to be efficacious in inducing regression of IH [3] [4] [5] [6] . Topical timolol maleate, a nonselective β-antagonist with a lipophilic moiety that enhances transdermal absorption, induces regression of periocular IH with minimal side effects [3] [4] [5] [6] . It is increasingly considered an alternative option to oral propanolol not only for superficial, but also deep periocular IHs [5] [6] [7] .
Despite their therapeutic success, the mechanism of action of β-adrenergic antagonists in the treatment of IH is not well understood. We describe the first histopathological and transmission electron microscopy observations from treated periocular IHs excised at 1 week and 24 months following initiation of topical timolol maleate therapy. The findings provide novel insights into the mechanisms of action of β-adrenergic antagonists in the treatment of IH.
Case Report
Case 1 A 10-week-old Caucasian boy presented with a left anterior orbital lesion above the medial canthus, causing lateral displacement of the globe and mild ptosis (Fig. 1a) . It was first noticed by the parents at 3 weeks of age and had been growing rapidly ever since. No significant birth, general medical and family history was given. Ocular examination was otherwise normal. MRI of the orbits was in keeping with an infantile hemangioma. An initial trial of topical timolol maleate 0.5%, applied by rubbing 3 drops twice daily into the skin overlying the lesion, was commenced, as described previously [4] [5] [6] , but no significant effect was seen after a week. Therefore, an urgent diagnostic orbital biopsy was performed (Fig. 1b) . Hematoxylin and eosin (H&E) staining confirmed a typical capillary hemangioma in its active proliferative phase with back-toback capillary-sized vessels, some of which lacked lumens (Fig. 2a) . Immunohistochemistry of the lesion demonstrated the presence of CD31- (Fig. 2b) , CD34-and GLUT-1-positive (not shown) endothelial cells, surrounded by smooth muscle actin (SMA)-positive pericytes (Fig. 2c) . Conspicuous apoptotic bodies were seen at the level of the endothelial cells ( Fig. 2d-f ), a feature that was not observed in an untreated capillary hemangioma (not shown). Transmission electron microscopy (TEM) confirmed endothelial cell apoptosis (Fig. 2g) .
Case 2
An 8-month-old Caucasian girl presented with a large superficial IH involving the right upper lid (Fig. 3a) . This 'strawberry nevus' was first noted by the parents a few weeks after birth and had rapidly increased in size until the age of 4 months, when it stopped growing. Birth, and medical and family history were unremarkable. No orbital involvement was evident with full extraocular movements, no strabismus and no proptosis. Although the infant appeared to object equally to occlusion of either eye, indicative of symmetrical visual acuity, she was adopting an abnormal head posture with chin elevation to minimize partial encroachment of the visual axis by the overhanging upper lid IH.
Topical timolol maleate 0.5%, 3 drops applied twice daily to the skin overlying the IH, was commenced in the same way as described above. Blanching and softening of the lesion was seen within a week, followed by progressive involution over 24 months of topical timolol treatment with no reported side effect. After the involution of the IH mass, the residual excess skin lid tissue (Fig. 3b ) was excised at 24 months (Fig. 3c) to further improve cosmesis at the parents' behest.
H&E sections demonstrated large areas of regressed vessels, characterized by concentric eosinophilic material obliterating the original lumen and interspersed with some residual vessels (Fig. 4a, b) . Immunohistochemistry demonstrated collagen IV positivity of the eosinophilic material, confirming it to be basement membrane type material (Fig. 4c) . While residual vessels showed marked anti-SMA positivity in their walls, the obliterated vessels showed scanty anti-SMA staining only, indicative of pericyte loss (Fig. 4d) . TEM of the effete vessels showed concentric Color version available online layers of basal lamina, containing dystrophic calcium deposits and occasionally surrounded by thin cytoplasmic processes of pericytes (Fig. 4e) . No apoptotic bodies were seen. Comparison was made with TEM of spontaneously regressed capillary hemangioma, which showed diffusely packed collagen IV within the interstitial matrix and some fibrillar collagen (Fig. 4f) . No concentric collagen IV deposition, pericyte processes or calcific bodies were seen.
Discussion
Several molecular mechanisms have been hypothesized to account for the effects of β-adrenergic blockade on capillary hemangiomas, based on existing understanding of the noradrenaline signaling pathways, but with little formal histopathologic evidence [8] . It was thought that an early vasoconstrictive effect, seen as reduced redness and rapid softening of the lesion, was possibly due to reduced nitric oxide synthesis signaled via adenylyl cyclase and cyclic AMP-dependent protein kinase A within the endothelial cells. Intermediate effects on the cessation of hemangioma growth has been attributed to the inhibition of hypoxia-inducible factor (HIF)-1, associated with reduced production of proangiogenic factors such as vascular endothelial growth factor, basic fibroblast growth factor and matrix metalloproteinases [9] . As a long-term effect, β-blockade was also thought to promote apoptosis by inhibiting endothelial cell survival signaling mediated by the anti-apoptotic tyrosine kinase (SRC).
We here report the first histopathological and electron microscopic evidence of the cellular reactions to topical β-blockade in vivo at both early (1 week) and late (24 months) time points following the initiation of topical timolol treatment in 2 children. Apoptosis was observed within IH at 1 week of topical β-adrenergic inhibition, supporting a prominent role for β-adrenergic inhibition in the disruption of endothelial cell survival during the proliferative phase of hemangioma growth. This would be consistent with in vitro studies showing that hemangioma-derived endothelial cells express both β 1 -and β 2 -adrenergic receptors and propranolol treatment caused increased levels of apoptosis [10] . Similarly, apoptosis was also previously observed in two specimens of IH resected in patients undergoing propranolol treatment [11] .
The difference in the rate of clinical response to topical timolol maleate in the 2 cases likely relates to the degree of drug penetration into the different depths of the hemangiomas (deep in case 1 and more superficial in case 2). One might ask why β-adrenergic inhibition would trigger apoptosis in IH but not in other tissues normally regulated by the β-adrenergic system, such as the heart and lungs? In cardiomyocytes, noradrenaline derived from the postganglionic sympathetic neurons appears to induce apoptosis through preferential stimulation of (proapoptotic) β 1 -over (antiapoptotic) β 2 -adrenoreceptors [12] . In contrast, the lack of sympathetic innervation in IH means that circulatory adrenaline, which stimulates β 1 -and β 2 -receptors equally, might normally elicit an antiapoptotic effect overall. Therefore, propranolol might exert its action by shifting the balance of β 1-and β 2 -adrenergic signaling within IH towards apoptosis. Another possibility is that the propranolol-induced apoptotic response requires synergistic input from the HIF pathway and is therefore specific to hypoxic tissue. This would be consistent with the expression of GLUT1 by endothelial cells in IH, as it is upregulated by HIF-1 [13] . Interestingly, propranolol has recently been shown to reduce the chance of disease progression in retinopathy of prematurity [14] . The mechanism of action is thought to be analogous to the effect in IH in that β-blockade is thought to reduce vascular endothelial growth factor expression (and angiogenesis) within the hypoxic retina by inhibition of HIF-1 and nitric oxide synthase.
When comparing spontaneously regressed IH with β-antagonist-treated IH, distinct morphological differences were observed. The former was characterized by diffuse collagen deposition and interstitial fibrosis. In contrast, treated IH showed concentric collagen IV deposition within obliterated vessel lumen, suggestive of waves of endothelial cell apoptosis, leaving behind layers of basement membrane deposits as a stress response. The observation of preserved but scanty pericytes surrounding obliterated vessel lumens in treated IH would suggest that timolol selectively induced the regression of endothelial cells with relative sparing of pericytes.
Although β-adrenergic antagonists have shown clinical efficacy in the treatment of IH, their mechanisms of action are still not well understood. These first histopathological and electron microscopic findings of early and late topical β-blockade provide support for the early induction of endothelial cell apoptosis and endovascular occlusion through concentric deposition of collagen IV as key outcomes of β-blocker-induced regression of IH. Further understanding of the mechanisms involved in this process will hopefully lead to optimization of the efficacy, dosing and duration of β-blocker treatment in infantile hemangioma as well as provide new insights into similar other disease processes and open new approaches for their possible treatment with β-blockers.
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